Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,111
datasets available to search
ShareScore release 0.9.0
Dataset results
2,111 results for “bevacizumab”
Nivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM
ClinicalTrials.gov study NCT03452579. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity
ClinicalTrials.gov study NCT02390531. IPD Sharing: YES. Countries: 1. Publications: 5.
Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma
ClinicalTrials.gov study NCT00879437. IPD Sharing: YES. Countries: 1. Publications: 1.
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov study NCT00262847. IPD Sharing: Not stated. Countries: 4. Publications: 9.
Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab
ClinicalTrials.gov study NCT00321100. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response
ClinicalTrials.gov study NCT00807573. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Phase II Study of Bevacizumab (Avastin®) in Myelofibrosis
ClinicalTrials.gov study NCT00667277. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Bevacizumab and Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma
ClinicalTrials.gov study NCT00387751. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients
ClinicalTrials.gov study NCT00055237. IPD Sharing: NO. Countries: 1. Publications: 1.
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01107626. IPD Sharing: YES. Countries: 1. Publications: 1.
Bevacizumab in Metastatic Renal Cancer
ClinicalTrials.gov study NCT02627144. IPD Sharing: Not stated. Countries: 1. Publications: 1.
BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT00528567. IPD Sharing: Not stated. Countries: 40. Publications: 2.
Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma
ClinicalTrials.gov study NCT00868192. IPD Sharing: Not stated. Countries: 1. Publications: 43.
Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65)
ClinicalTrials.gov study NCT05116189. IPD Sharing: YES. Countries: 25. Publications: 1.
Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
ClinicalTrials.gov study NCT00569127. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Bevacizumab + Endocrine Treatment vs Endocrine Treatment as First Line in Postmenopausal Women
ClinicalTrials.gov study NCT00545077. IPD Sharing: Not stated. Countries: 2. Publications: 3.
BELIEF (Bevacizumab and ErLotinib In EGFR Mut+ NSCLC)
ClinicalTrials.gov study NCT01562028. IPD Sharing: Not stated. Countries: 8. Publications: 4.
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
ClinicalTrials.gov study NCT01627249. IPD Sharing: Not stated. Countries: 1. Publications: 22.
AVAPERL1 Study: A Study of Avastin (Bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00961415. IPD Sharing: Not stated. Countries: 12. Publications: 1.
A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT02519348. IPD Sharing: YES. Countries: 9. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.